Company Profile
Lisata Therapeutics Stock Price, News & Analysis
- Ticker:
- LSTA
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Lisata Therapeutics is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Stock performance
3.47 USD (0.00%)
Close
Last updated: June 23, 2026 at 00:00
31.6M USD
Market cap
Why the stock is moving
LSTA is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Lisata Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Lisata Therapeutics is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Business Model Characteristics
Lisata Therapeutics follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.
Position Within the Biotechnology Landscape
Compared with more mature healthcare names, Lisata Therapeutics sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
Lisata Therapeutics Announces Commencement of Tender Offer by Kuva Labs Inc.
Source: Lisata Therapeutics
- 02
- 03
Lisata Therapeutics and Catalent Announce Global Antibody-Drug Conjugate (ADC) License Agreement
Source: Lisata Therapeutics
- 04
Lisata Therapeutics to Present at LD Micro Main Event XIX
Source: Lisata Therapeutics
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Lisata Therapeutics (LSTA)?
Lisata Therapeutics (LSTA) most recently closed at 3.47 USD, a 0.00% move versus the previous session.
What is the market cap of Lisata Therapeutics (LSTA)?
Lisata Therapeutics currently has a market capitalization of 31.6M USD on BioPharmSignal.
What does Lisata Therapeutics do?
Lisata Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
On which exchange is LSTA stock listed?
Lisata Therapeutics (LSTA) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Lisata Therapeutics is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts., Biotechnology.
What is Lisata?
Lisata Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Which conditions is Lisata Therapeutics targeting with Lisata?
Lisata Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
What is Therapeutics?
Lisata Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.